NCT02638428 2020-03-19Genomics-Based Target Therapy for Children With Relapsed or Refractory MalignancySamsung Medical CenterPhase 2 Unknown90 enrolled
NCT00551252 2007-10-30A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant MesotheliomaGruppo Italiano MEsoteliomaPhase 2 Unknown56 enrolled